We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Ultram Recall to Cost Biovail Millions of Dollars
Ultram Recall to Cost Biovail Millions of Dollars
January 13, 2009
Toronto-based Biovail said the voluntary recall last week of its chronic pain management drug Ultram ER will cost it a total of $7.4 million in the fourth quarter of 2008.